These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Variation of matrix metalloproteinase 1 and 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoarthritis. Abd-Allah SH; Shalaby SM; Pasha HF; El-Shal AS; Abou El-Saoud AM Genet Test Mol Biomarkers; 2012 Jan; 16(1):15-20. PubMed ID: 21770773 [TBL] [Abstract][Full Text] [Related]
4. The Association of Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550 [TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma. Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394 [TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217 [TBL] [Abstract][Full Text] [Related]
7. The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China. Shan K; Ying W; Jian-Hui Z; Wei G; Na W; Yan L Mol Hum Reprod; 2005 Jun; 11(6):423-7. PubMed ID: 15879464 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. Bradbury PA; Zhai R; Hopkins J; Kulke MH; Heist RS; Singh S; Zhou W; Ma C; Xu W; Asomaning K; Ter-Minassian M; Wang Z; Su L; Christiani DC; Liu G Carcinogenesis; 2009 May; 30(5):793-8. PubMed ID: 19321798 [TBL] [Abstract][Full Text] [Related]
9. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Dörr S; Lechtenböhmer N; Rau R; Herborn G; Wagner U; Müller-Myhsok B; Hansmann I; Keyszer G Arthritis Res Ther; 2004; 6(3):R199-207. PubMed ID: 15142265 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies. Peng B; Cao L; Wang W; Xian L; Jiang D; Zhao J; Zhang Z; Wang X; Yu L Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588 [TBL] [Abstract][Full Text] [Related]
12. Promoter polymorphism MMP-1 (-1607 2G/1G) and MMP-3 (-1612 5A/6A) in development of HAND and modulation of pathogenesis of HAND. Singh HO; Marathe SD; Nain S; Samani D; Nema V; Ghate MV; Gangakhedkar RR J Biosci; 2017 Sep; 42(3):481-490. PubMed ID: 29358561 [TBL] [Abstract][Full Text] [Related]
13. Matrix Metalloproteinase-1 Genetic Polymorphism in Breast Cancer in Taiwanese. Su CH; Lane HY; Hsiao CL; Liu LC; Ji HX; Li HT; Yen ST; Su CH; Hsia TC; Chang WS; Tsai CW; Bau DT Anticancer Res; 2016 Jul; 36(7):3341-5. PubMed ID: 27354592 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis. Rech TF; Moraes SB; Bredemeier M; de Paoli J; Brenol JC; Xavier RM; Chies JA; Simon D Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002595 [TBL] [Abstract][Full Text] [Related]
15. Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins. Kurzawski M; Modrzejewski A; Pawlik A; Droździk M Clin Exp Dermatol; 2009 Jul; 34(5):613-7. PubMed ID: 19508478 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk. Guan X; Wang X; Luo H; Wu J; Zhang X; Wu J Med Sci Monit; 2014 Nov; 20():2269-74. PubMed ID: 25391977 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of MMP1 and MMP3 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma. Tsironi EE; Pefkianaki M; Tsezou A; Kotoula MG; Dardiotis E; Almpanidou P; Papathanasiou AA; Rodopoulou P; Chatzoulis DZ; Hadjigeorgiou GM Mol Vis; 2009 Dec; 15():2890-5. PubMed ID: 20038976 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. Lièvre A; Milet J; Carayol J; Le Corre D; Milan C; Pariente A; Nalet B; Lafon J; Faivre J; Bonithon-Kopp C; Olschwang S; Bonaiti-Pellié C; Laurent-Puig P; BMC Cancer; 2006 Nov; 6():270. PubMed ID: 17125518 [TBL] [Abstract][Full Text] [Related]
19. Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population. Srivastava P; Gangwar R; Kapoor R; Mittal RD Dis Markers; 2010; 29(1):37-46. PubMed ID: 20826916 [TBL] [Abstract][Full Text] [Related]
20. Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis. Abd-Allah SH; El-Shal AS; Shalaby SM; Pasha HF; Abou El-Saoud AM; Abdel Galil SM; Mahmoud TA IUBMB Life; 2015 Dec; 67(12):934-42. PubMed ID: 26510114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]